Page 29 - Hal Barron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As several pharmaceutical companies rush to test their vaccines and other products in relation to the new variant, British drugmaker GSK has claimed that its antibody-based COVID-19 therapy is effective against the new Omicron variant of coronavirus. GSK has revealed that as per new data from the early stages of its study, their antibody-test Covid therapy with US partner Vir Biotechnology works against all 37 identified mutations of coronavirus, including the latest Omicron variant.

Sotrovimab is effective against all 37 identified mutations in the spike protein, GSK says

A COVID-19 antibody drug approved for emergency use in the U.S.

02.12.2021 -  – Preclinical data demonstrate sotrovimab, authorized in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron – – Data to be confirmed by further in vitro pseudo-virus ...

Investegate announcements from GlaxoSmithKline PLC, Sotrovimab retains its activity vs Omicron variant